Duan Qiuhong, Wang Wei, Xiong Hua, Xiao Juanjuan, Xiao Han, Zhu Feng, Lu Hui
Translational Medical Center, Huaihe Hospital, Henan University, Kaifeng, Henan, 475000, PR China.
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China.
Oncogene. 2025 Mar;44(9):587-600. doi: 10.1038/s41388-024-03246-3. Epub 2024 Dec 4.
Cervical cancer is the most common gynecologic cancer. Autophagy is involved in the progression of CCa. ULK1 is a crucial kinase in autophagy initiation. However, few studies have investigated the role of ULK1 phosphorylation at tyrosine residues in the progression of CCa, and the underlying mechanism remains elusive. In this study, we demonstrated that JAK2 is a novel upstream kinase that phosphorylates ULK1 at the tyrosine site. JAK2 interacts with and phosphorylates ULK1 at Tyr1007. The phosphorylation of ULK1 at Y1007 increases its activity and stability, activates autophagy, and promotes the progression of CCa. We further showed that the phosphorylation of ULK1 at Y1007 is a predictive marker of CCa patient outcome. Furthermore, we identified SRPK1 as a potential downstream substrate of ULK1 to promote the progression of CCa. Our research sheds light on the molecular mechanism of CCa progression, through JAK2/ULK1 axis, and emphasizes the phosphorylation of ULK1 at Y1007 as a predictor of CCa.
宫颈癌是最常见的妇科癌症。自噬参与宫颈癌(CCa)的进展。ULK1是自噬起始过程中的关键激酶。然而,很少有研究探讨ULK1酪氨酸残基磷酸化在宫颈癌进展中的作用,其潜在机制仍不清楚。在本研究中,我们证明JAK2是一种新型上游激酶,可在酪氨酸位点磷酸化ULK1。JAK2与ULK1相互作用并在Tyr1007位点使其磷酸化。ULK1在Y1007位点的磷酸化增加了其活性和稳定性,激活自噬,并促进宫颈癌进展。我们进一步表明,ULK1在Y1007位点的磷酸化是宫颈癌患者预后的预测标志物。此外,我们确定SRPK1是ULK1的潜在下游底物,可促进宫颈癌进展。我们的研究通过JAK2/ULK1轴揭示了宫颈癌进展的分子机制,并强调ULK1在Y1007位点的磷酸化作为宫颈癌的预测指标。